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Cellular/Molecular
Fast Phasic Release Properties of Dopamine Studied with a
Channel Biosensor
Geraldine J. Kress,1Hong-Jin Shu,1 Andrew Yu,1 Amanda Taylor,1 Ann Benz,1 Steve Harmon,2
and StevenMennerick1,2,3
Departments of 1Psychiatry and 2Anatomy and Neurobiology and 3Taylor Family Institute for Innovative Psychiatric Research, Washington University
School of Medicine, St. Louis, Missouri 63110
Fewother neurotransmitters are of as intense interest to neuropsychiatry andneurology as dopamine, yet existing techniques tomonitor
dopamine release leave an important spatiotemporal gap in our understanding. Electrochemistry and fluorescence imaging tools have
been developed to fill the gap, but these methods have important limitations. We circumvent these limitations by introducing a
dopamine-gated chloride channel into rat dorsal striatal medium spiny neurons, targets of strong dopamine innervation, thereby
transforming dopamine from a slow transmitter into a fast transmitter and revealing new opportunities for studying moment-to-
moment regulation of dopamine release. We demonstrate pharmacological and biophysical properties of the channel that make it
suitable for fast, local dopamine measurements, and we demonstrate for the first time spontaneous and evoked responses to vesicular
dopamine release in the dorsal striatum. Evoked dopamine currents were separated into a fast, monosynaptic component and a slower-
rising and decaying disynaptic component mediated by nicotinic receptor activation. In summary, LGC-53 represents a dopamine
biosensor with properties suitable for temporal separation of distinct dopamine signals in targets of dopamine innervation.
Key words: dopamine release; ligand-gated ion channel; nicotinic; presynaptic; striatum
Introduction
Rapid, moment-to-moment changes in transmitter release un-
derlie behavioral adaptation and short-term forms of memory
(Zucker and Regehr, 2002). In the case of dopamine (DA), alter-
ation in DA release represents a common early effect of many
addictive drugs, and changes in DA release may underlie early
pathology in diseases such as Parkinson’s (Garcia-Reitbo¨ck et al.,
2010; Scott et al., 2010). Unfortunately, there are significant bar-
riers to the study of short-term or rapid changes in DA release.
DA activates G-protein-coupled receptors (GPCRs) that are
linked indirectly to changes in membrane excitability. This typi-
cally makes endogenous GPCR-mediated signals poor sensors of
amount and timing of DA release. In contrast, ligand-gated ion
channels at “fast” glutamate, GABA, glycine, and peripheral nic-
otinic synapses (e.g., the neuromuscular junction) are high-
fidelity sensors of local, synaptic transmitter release and are
directly responsible for such fundamental observations as the
quantal basis of release, paired-pulse facilitation/depression, and
synchronous versus asynchronous transmitter release.
Limitations hamper other, non-receptor probes ofDA release.
Electrochemistry and microdialysis lack the spatial and temporal
resolution to study rapid changes in transmitter release. They are
best suited in situ to measure volumetric, spatiotemporally aver-
aged DA transients because probes are too large to be positioned
in the synapse, although amperometry can detect single vesicles
when suitably placed (Staal et al., 2004). Fluorescent presynaptic
reporters of DA release have been used recently (Sankaranaray-
anan et al., 2000; Daniel et al., 2009; Gubernator et al., 2009;
Garcia-Reitbo¨ck et al., 2010; Rodriguez et al., 2013). Single pre-
synaptic terminals can be visualized in dissociated cultures and in
some cases tissue slices, but the methods do not have temporal
sensitivity comparable with postsynaptic currents (PSCs; Guberna-
tor et al., 2009;Rodriguez et al., 2013).D2-activatedpotassiumchan-
nels have sensitivity to detect evoked (Ford et al., 2009) and quantal
(Gantz et al., 2013) DA release but apparently only for specialized
dendritic release within the substantia nigra/ventral tegmental area.
The above limitations have sustained an important gap in our
understanding of basal DA transmission, alterations in release
wrought by drugs of abuse, and changes related to pathology. To
fill this gap, we introduce the use of a DA-gated chloride channel
(LGC-53) from Caenorhabditis elegans (Ringstad et al., 2009) to
study DA release from mammalian DA terminals in the dorsal
striatum. We first examine pharmacological and biophysical
properties of the receptor important in the use of LGC-53 as a
biosensor of synaptic DA. By virally introducing LGC-53 into
striatal medium spiny neurons, we demonstrate evoked and
spontaneous phasic currents attributable to DA release. We dis-
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tinguish temporally distinct components of DA release evoked by
local stimulation: fast monosynaptic DA release and a surprising
large and slow disynaptic component mediated by nicotinic re-
ceptor activation. We conclude that heterologous expression of
LGC-53 in normal targets of DA innervation is a new tool for
studying a previously poorly characterized spatiotemporal do-
main of DA release.
Materials andMethods
Molecular biology. A wild-type (WT) C. elegans LGC-53 DNA sequence
was used for Xenopus oocyte expression studies (Ringstad et al., 2009).
The WT LGC-53 sequence can be found at the National Center for Bio-
technology Information as accession number NM_171812.5. For mam-
malian expression, the sequence was optimized for mammalian codon
usage, the signal sequence was optimized to that of rat 1 GABAA recep-
tor (GABAAR) subunit, and predicted ER retention sequences were mu-
tated to improve surface expression (Epoch Life Sciences). These changes
to the predicted retention sequences were as follows: R398A, R399A,
R400A, R439A, R440A, R441A, and K442A.
Solutions. Bath solutions for the various experiments are referred to by
letter below. Solution A (oocyte culture) contained 96 mM NaCl, 1 mM
KCl, 1 mM MgCl2, 2 mM CaCl2, and 10 mM HEPES at pH 7.4, supple-
mented with 5 mM pyruvate, 100 U/ml penicillin, 100 g/ml streptomy-
cin, and 50 g/ml gentamycin. Solution B (oocyte recording) contained
the following (in mM): 96 NaCl, 1 KCl, 1 MgCl2, 2 CaCl2, and 10 HEPES
at pH 7.4. Solution C (culture recording) contained the following (in
mM): 138NaCl, 4 KCl, 1MgCl2, 2 CaCl2, 10 glucose, and 10HEPES at pH
7.4. Solution D contained the following (in mM): 87 NaCl, 75 sucrose, 25
NaHCO3,1.25 NaH2PO4, 2.5 KCl, 0.5 CaCl2, 3 MgCl2, and 25 glucose.
Solution E contained the following (inmM): 92 choline chloride, 2.5 KCl, 30
NaHCO3,1.25NaH2PO4, 2CaCl2, 1MgCl2, 25glucose, 20HEPES,5 sodium
ascorbate, 2 thiourea, and 3 sodium pyruvate. Solution F contained the fol-
lowing (inmM): 125NaCl, 25NaHCO3, 1.25NaH2PO4, 2.5 KCl, 2 CaCl2, 1
MgCl2, and 25 glucose.
Standard whole-cell pipette solutions included the following (in mM):
130 potassium gluconate, 4 NaCl, 5 EGTA, 0.5 CaCl2, and 10HEPES, pH
7.3. For some experiments, when indicated, cesium gluconate, cesium
methanesulfonate, cesium chloride, or potassium chloride substituted
for potassium gluconate. For slice studies, 4 mMQX-314 was included in
the pipette solution.
Xenopus oocytes. Oocytes were harvested and prepared by standard
methods. Briefly, stage V–VI oocytes were harvested from sexually ma-
ture female Xenopus laevis (Xenopus One) under 0.1% tricaine (3-
aminobenzoic acid ethyl ester) anesthesia, according to protocols
approved by the Washington University Animal Studies Committee.
Oocytes were defolliculated by shaking for 20 min at 37°C in collagenase
(2 mg/ml) dissolved in calcium-free solution containing the following
(in mM): 96 NaCl, 2 KCl, 1 MgCl2, and 5 HEPES at pH 7.4.
Constructs were prepared in pGEMHE plasmids containing Xenopus
-globin 5 and 3 UTRs to stabilize mRNA. Capped mRNA encoding
WT LGC-53 was transcribed in vitro using the mMESSAGE mMachine
Kit (Ambion) from linearized vectors containing receptor coding re-
gions. Subunit transcripts were injected in a volume of up to 20–50 nl
and 10–50 ng of total RNA 16–24 h after defolliculation. Oocytes were
incubated up to 5 d at 18°C in solution A.Xenopus oocytes were recorded
using standard two-electrode voltage-clamp recordings. Oocytes were
cultured in bath solution A and recorded in bath solution B using pi-
pettes filled with 3 M KCl.
Two-electrode voltage-clamp experiments were performed with an
OC725 amplifier (Warner Instruments) 2–5 d after RNA injection.
The extracellular recording solution was solution B. Intracellular re-
cording pipettes were filled with 3 M KCl and had open tip resistances
of 1 M. DA and modulators were applied from a common tip via
a gravity-driven multibarrel delivery system. Except when indicated,
cells were voltage clamped at 70 mV, and the peak current or the
current at the end of 30 s was measured as indicated. Nicotinic antag-
onists were preapplied for 5 min before challenge with coapplied DA
and antagonist.
Cultures. HEK 293T and Neuro 2A (N2a) cells were cultured under
standard conditions and transiently transfected with pcDNA3.1 vector
encoding LGC-53. RFP or GFP was cotransfected as a marker of expres-
sion. Primary neuronal culture details have been published previously.
Briefly, postnatal rat striatal neurons were seeded onto a monolayer or
island of astrocytes prepared as described previously (Moulder et al.,
2007) and grown for 10–14 d before use in synaptic studies.
For transfected cell lines and primary neurons, whole-cell recordings
were performed in recording solution C. To isolate LGC-53 PSCs, we
used 1–5 M NBQX, 25–50 M D-APV, and 5–10 M gabazine. In some
experiments, 100 M picrotoxin was also added as described.
Lentivirus injections and striatal slices. Lentivirus particles were pre-
pared by the Hope Center Viral Vector Core at Washington University.
Constructs used the FCIV vector, a lentiviral expression vector that
drives gene expression under control of the ubiquitin C promoter (Li et
al., 2010). In some cases, lentivirus was prepared in a vector in which
expression was under the control of the synapsin I promotor, which was
more effective than FCIV when injected into striatum of more mature
animals (older than postnatal week 3). Coexpression of Venus fluores-
cent protein was controlled by an IRES sequence. Lentiviruses were pro-
duced in HEK 293T cells. Viral particles were stereotactically injected
into P5 rat pups (FCIV vector) or postnatal week 3 pups (Synapsin I
promoter), followed by slice harvest at P20–P22 or P30–P40 for record-
ing. Coronal or horizontal slices were prepared with a Leica 1200S tissue
slicer in low-sodiumbufferD (see above). Slices were stored for 30min at
34°C in a low-sodium choline solution E (see above); thereafter, slices
were transferred to oxygenated solution F stored at 25°C. Slices were
perfused at 2–4 ml/min with oxygenated saline F at25°C with antago-
nists added as indicated. Whole-cell recordings from slices were per-
formed using pipette solutions of the compositions given above.
Stimulation of evoked striatal PSCs was achieved with a whole-cell
pipette filled with bath solution and connected to a stimulus isolator,
with stimulus amplitudes of 5–300 A at 100–150 s. A 500 ms paired-
pulse interval was used for the paired-pulse experiments, with a sweep
interval of 60 s. For the study of nicotinic acetylcholine receptor
(nAChR) and D2 pharmacology in slices, a nearly maximal PSC was
elicited before nAChR antagonist or D2 agonist application by varying
the stimulus intensity up to 250 A with a 150 s pulse width. This
helped to ensure the presence of the early PSC. For matched-amplitude
comparisons of early and late PSCs, stimulus strength was adjusted to
produce a 1000  150 pA PSC1 amplitude in the presence of 1 M
dihydro--erythroidine (DHE) (early PSC) or without antagonist
(compound PSC). The standard holding potential was70 to80 mV
unless otherwise indicated. Voltages, including the current–voltage rela-
tionships in the figures, were not corrected for liquid junction potentials.
Imaging. Images were acquired on an upright Nikon microscope
equipped with infrared differential interference contrast optics, a QIm-
aging camera, and MetaMorph software (Molecular Devices). Images
were adjusted in NIH ImageJ or Adobe Photoshop (Adobe Systems) for
brightness, contrast, and pseudocoloring.
Data analysis. Electrophysiology data files were analyzed with Clamp-
fit (versions 9.2 and 10.4; Molecular Devices) or imported into Igor
(version 6.3; Wavemetrics) for analysis with custom-written routines or
the plug-in NeuroMatic. Graphs were constructed with SigmaPlot (ver-
sion 12.5). PSC amplitudes weremeasured from the baseline 5ms before
the stimulation. For biphasic responses, the first component (peak
within 17ms from the stimulus onset) was termed the early PSC, with the
latter component termed the late PSC. Paired-pulse ratios were calcu-
lated after subtracting baseline current 5 ms before each stimulus. The
half-decay was calculated from the peak PSC amplitude to the 50% am-
plitude. Statistical comparisons were performed in GraphPad Prism
(version 6; GraphPad Software) using tests as indicated. All data in fig-
ures and text are presented as mean SE.
Results
Pharmacological and biophysical properties relevant to
fast biosensor
To serve as a sensor of quasi-synaptic or synaptic DA release rather
than ambient, low-level or volumetric transmitter, LGC-53 should
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have a relatively lowagonist affinity.Consis-
tent with a previous report (Ringstad et al.,
2009), we found that LGC-53 peak cur-
rents were activated by DA with an EC50
of 6.4 M (Fig. 1A,B). This value is
comparable with receptors for fast
transmitters: a slightly higher EC50 than
glutamate gating NMDARs and slightly
lower than glutamate gating AMPARs or
GABA acting at GABAARs (Patneau and
Mayer, 1990; Mortensen et al., 2010). The
EC50 is much higher thanmammalianDA
GPCRs, with Kd values ranging from 1 to
30 nM (Seeman and Van Tol, 1994). Al-
though under the non-steady-state condi-
tions of synaptic release in intact cells high
DA concentrations may be needed to ac-
tivate GPCRs (Ford et al., 2009), a high
EC50 for LGC-53 suggests that detection
of low, submicromolar ambient concen-
trations will be minimized and that detec-
tion of high, synaptic concentrations will
be favored.
Previous work has suggested that
LGC-53 is an anion channel. To confirm
this, we compared reversal potentials of
LGC-53, gated by DA, with GABAARs,
gated by GABA and well-characterized
anion channels (Bormann et al., 1987).
LGC-53 expressed in Xenopus oocytes ex-
hibited a reversal potential near 20 mV
and was statistically indistinguishable
from the reversal potential of GABA act-
ing at 122 GABAAR subunits in the
same batches of oocytes (data not shown).
However, a difference in anionpermeability
compared with GABAARs was revealed in
whole-cell recordings from transfected
mammaliancells, inwhichalternative intra-
cellular anions substituted for chloride.
GABA-gated GABAA channels exhibited
weak gluconate and methanesulfonate per-
meability; these anions led to indistinguish-
able, negative reversal potentials, consistent
with classic studies on GABAARs and gly-
cine receptors (Bormannet al., 1987).How-
ever, DA-gated currents from LGC-53
exhibited significantly more positive rever-
sal potentials when methanesulfonate was
used as an anion than when gluconate
was used (Fig. 1C,D). This result sug-
gests atypical anion permeability for
LGC-53 relative to other cys-loop chlo-
ride channels, such as the GABAAR (Fig.
1D). The observation has practical im-
plications for the choice of pipette solu-
tions in whole-cell recordings to
optimize driving force on DA-activated
LGC-53 currents. When LGC-53-trans-
fected cells were filled with CsCl, DA-gated currents exhibited
the expected reversal potential near 0 mV (data not shown).
Some transmitter receptorsmay exhibit limited sensitivity as a
result of desensitization properties (Trussell and Fischbach, 1989;
Zorumski et al., 1996; Overstreet et al., 2000). In striatal neurons
(n 4) and HEK 293T cells (n 4) transfected with LGC-53, 30
M DA elicited characteristic biexponential macroscopic desen-
sitization to application of 30MDA(fast 128 12ms, slow
Figure 1. LGC-53 is an atypical anion channel.A, Responses of an oocyte expressing LGC-53 to increasing concentrations of DA.
B, Concentration–response curve of peak currents at the indicatedDA concentrations, normalized to responses at 100MDA (n
6). The solid line is a fit to the Hill equation, which estimated an EC50 of 6.4M and a Hill slope of 1.8. C, N2a cells were transfected
with LGC-53DNAand challengedwithDA (30M) in cells filledwith the indicatedwhole-cell pipette solutions.D, Current–voltage
curves compare anion permeability for LGC-53 expressed in N2a cells (30 M DA; n 4 for each pipette solution) and GABAA




preapplication timeof 10 swas not observed at concentrations below3M (n 5).MeS,methanesulfonate.
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1354 189ms, 48 4% fast; Fig. 1E). After desensitization by 30
MDA, recovery from desensitization was rapid, with an average
time constant of 1.3 s and full recovery by 6 s (Fig. 1E,F). This
recovery time constant compares favorably with the slow com-
ponent of GABAAR and NMDAR recovery from desensitization
(Tong et al., 1995) but is slower than AMPAR recovery (Trussell
and Fischbach, 1989). Because DA may be tonically present at
significant concentrations (Goto et al., 2007), steady-state desen-
sitization could be an impediment to detection of transient, high
DA concentrations such as those found at synaptic junctions
(Ford et al., 2009). However, when conditioned with concentra-
tions of DA up to 3 M, LGC-53 showed little desensitization
(Fig. 1G,H), suggesting that ambient DA levels are unlikely to
alter the sensitivity of LGC-53 as a synaptic or quasi-synaptic
biosensor.
To serve as a faithful sensor of DA, LGC-53 should exhibit
selectivity over other amine neurotransmitters. We found that,
when evaluated at 100 M, norepinephrine (NE) and epineph-
rine gated10% of the response to DA (Fig. 2A), consistent with
high, although not perfect, selectivity for DA. Average peak re-
sponsiveness to the alternate agonists (100 M) was 10  1%
(NE) and 6  1% (epinephrine) of the response to DA. Sero-
tonin, histamine, and GABA failed to gate detectable LGC-53
currents at concentrations up to 100 M (n 5 oocytes exhibit-
ing responses to 100 M DA of5.0 0.5 A).
We screened LGC-53 against modulators of GluRs and
GABAARs. We started with compounds typically used for phar-
macological isolation (NBQX to block AMPARs and bicuculline,
picrotoxin, and gabazine to block GABAARs; Fig. 2B). LGC-53
exhibited unexpected sensitivity to antagonists of GABAARs. Bi-
cuculline strongly inhibited LGC-53 at concentrations typically
used to block GABA transmission (Fig. 2B,C). The antagonism
was essentially overcome with increased agonist concentration,
suggesting at least a partly competitive mechanism (Fig. 2C).
Other antagonists of GABAARs had weaker effects (Fig. 2B), and
LGC-53 also exhibited mild sensitivity to neurosteroids that po-
tently and allosterically inhibit (pregnenolone sulfate) or poten-
tiate (allopregnanolone, 35P)GABAAR function (Eisenman et
al., 2004; Fig. 2B). These observations suggest that caution is
warranted when choosing the pharmacological tools used to iso-
late LGC-53 responses in native tissue.
Previous results suggested that LGC-53 obeys a pharmacology
that ismost similar toD2-typemammalian receptors (Ringstad et
al., 2009). We confirmed this observation by screening various
ligands at 50 M against currents generated by 10 M DA. We
found that, among D2 antagonists tested, spiperone was themost
effective antagonist (Fig. 3A,B). However, the concentration of
spiperone required to substantially inhibit LGC-53 responses was
significantly higher than the Ki at mammalian receptors, 0.06
and 0.08 nMKd at D2 and D4 receptors, respectively (Seeman and
Van Tol, 1994). The antagonism of LGC-53 by spiperone ap-
peared at least partly competitive, because its primary effect was
to shift the concentration–response profile of DA to the right
(Fig. 3C). Sulpiride (10 M), used in ensuing pharmacology ex-
periments, weakly suppressed 5 M DA currents (35  4% de-
pression; n  4). Nemonapride and haloperidol weakly
antagonized 5 M DA responses (Fig. 3A,B). When tested in
LGC-53-transfected striatal neurons, several additional D2 li-
gands tested had weak or no activity at 50 M (respiridone, 66
4% inhibition; raclopride, 24  15% potentiation; eticlopride,
19 12% inhibition; n 4 cells each). The D1 ligand SKF38393
(2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benazepine
HCl) also had little effect at 50 M (Fig. 3A,B).
Not all D2 antagonists behaved as LGC-53 antagonists. TheD2
antagonist 3-[[4-(4-chlorophenyl)-4-hydroxypiperidin-l-yl]methyl-
1H-indole (L741,626) had the interesting property of exhibiting
positive allosteric modulation of LGC-53 gating (Fig. 3D–H). At
Figure2. LGC-53 exhibits DA agonist selectivity but unexpected sensitivity to GABAR antag-
onists. A, Response of an LGC-53-expressing oocyte to 100 M DA and each of the indicated
agonists: NE, epinephrine (Epi), serotonin (5-HT), histamine, and GABA. Summary numbers are
in Results.B, Normalized responses showing the effect of variousmodulators coappliedwith 10
M DA to oocytes expressing LGC-53. n 4–6 oocytes for each. Screenswere performedwith
an interleaved presentation of DA alone and DA plus test modulator; reversibility verified that
small effects did not result from generalized rundown of DA responses. Because the initial
screens revealed an interaction between bicuculline and LGC-53 function, other positive and
negativemodulators of GABAAR function were screened at the indicated concentrations. These
included the endogenous neurosteroid allopregnanolone (35P), the sulfated neurosteroid
negative modulator pregnenolone sulfate (PS), and the high-potency negative modulator di-
picrylamine (DPA) (Chisari et al., 2011). C, The effect of bicuculline, the strongest inhibitor, was
overcome by increasing DA concentration (n 5 oocytes).
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concentrations above 10 M, L741,626 slowed macroscopic de-
sensitization of LGC-53 currents and enhanced steady-state DA
responses (Fig. 3D–H). L741,626 also slowed deactivation ofDA-
gated currents and directly gated channels at10M (Fig. 3E–H).
Although these observations suggest a potentially rich phar-
macology for LGC-53, we were concerned that ligands that mod-
ulate LGC-53 may have off-target effects at the concentrations
required tomodulate channel function (50M), orders ofmag-
nitude higher than concentrations used to modulate D2 recep-
tors. To address this concern, we tested the most active negative
and positive modulators, spiperone and L717,626, at 50 M on
evoked PSCs from hippocampal autaptic synapses, which use
glutamate as a neurotransmitter. Both compounds depressed
evoked AMPAREPSCs (34 10% for 50M spiperone, 55 9%
for 50 M L741,626; n 3 and 6). In both cases, this depression
appeared to arise primarily presynaptically, because it was asso-
ciated with reversible suppression (25  6%) of voltage-gated
sodium current. Similar glutamate EPSC suppression was ob-
served in acutely prepared brain slices containing striatum (50
M spiperone, 60 8% suppression; n 5). Thus, at concentra-
tions required to modulate LGC-53, spiperone and L717,626
have significant off-target effects.
DA-gated phasic currents in dissociated culture and
brain slices
Aided by biophysical andpharmacological information about the
advantages and limitations of LGC-53, we next evaluated the
utility of LGC-53 as a biosensor of vesicular DA release. Potential
challenges to this utility include expression levels and localization
of LGC-53. As a test of principle, we first sparsely transfected
primary striatal cultures with LGC-53 and loaded DA as a false
transmitter into striatal presynaptic terminals. Using previously
published protocols, we incubated cultures with DA during de-
polarization. Under these conditions, DA enters vesicles through
a combination of passive mechanisms and through reloading en-
docytosing vesicles (Kim et al., 2000; Zhang and Zhou, 2002).
After removal of extracellular DA, we established whole-cell re-
cordings from transfected or nontransfected striatal neurons in
the presence of antagonists of GluRs and GABAARs. Depolariza-
tion of the surrounding network elicited rapid, PSC-like currents
in transfected neurons but never in nontransfected neurons or in
neurons not previously loaded with DA (Fig. 4). These results
suggest that LGC-53 can be heterologously expressed at levels
sufficient to detect vesicular DA, albeit from an unknown vesic-
ular concentration.
To determine the time course of LGC-53-mediated currents
achieved at bona fide synaptic connections with single action
potential stimuli, we extended the false-transmitter loading pro-
Figure 3. LGC-53 is sensitive to D2 ligands, which can positively or negatively modulate. A,
Response of DA alone (5M; black trace) and in the presence of 50M of the indicated D1 and
D2 receptor ligands fromanoocyteexpressingLGC-53.B, Summaryof antagonist pharmacology
from four to six oocytes. Antagonists were preapplied and then coapplied with DA, and peak
4
current was normalized to DA alone. C, Spiperone (50 M) shifted the DA EC50 to the right,
suggesting a competitive interaction. Fits to the Hill equation exhibited a shift from an EC50 for
DA of 8.6M in the absence of spiperone to 43.9M in the presence of 50M spiperone (n
4 oocytes).D, The oocyte response to 5MDA in the absence andpresence of L741,626 (50M)
revealed potentiation. E, Response of a cultured striatal neuron expressing LGC-53 to 30 M
L741,626 preapplied and then coapplied with 30M DA (red trace). A baseline DA response is
shown in black. F, Summary of the effect of L741,626 on 30M DA-gated LGC-53 currents in
striatal neurons. Colors as in E. Measurements weremade of peak current (Ipeak), steady-state
current (Iss), the weighted desensitization time constant [taud(w)], and the time constant of
deactivation (tauoff), measured during agonist washout. *p 	 0.05. G, H, Concentration–
response characteristics for the effects of L741,626 on responses to 30 M DA transfected in
striatal neurons; n 6–7). L741,626 at the indicated concentrations was preapplied for 10 s
before co-application with DA. The summary in H is color coded to traces in G.
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tocol to striatal neurons cultured on astrocyte islands, which
form synaptic junctions that use GABA as a transmitter (Dubin-
sky, 1989). After DA loading, brief depolarization of solitary
neurons evoked inward, PSC-like currents in a subset of LGC-53-
positive neurons with confirmed responses to exogenous DA (10
M,20 pA, 4 of 13 cells). These events were strongly depressed
by 10 M DA in the presence of 10 M sulpiride, a mixture
designed to desensitize/suppress LGC-53 without engaging D2-
mediated presynaptic depression (Fig. 4C). DA-suppressed
events were never observed in cells without functionally detect-
able DA-gated responses (0 of 21 cells; p 	 0.05, Fisher’s exact
test). Thus, we interpret the evoked responses to be LGC-53-
mediated PSCs. These DA-sensitive evoked events had best-fit
decay time constants of 12.8  4.4 ms (n  4; range of 4.8–21
ms). Rise times (10–90%) of synaptically presented DA PSCs
were 3.6  0.9 ms. These rise and decay times put limits on the
expectations for synaptically generated PSCs. The results suggest
that, despite the lack of engineered synaptic localization signals,
sufficient LGC-53 is trafficked to synapses to mediate synaptic-
like PSCs under conditions in which synaptic junctions are hi-
jacked to release DA cargo.
To extend the biosensor approach to a bona fide DA circuit
that includes both morphologically synaptic and volumetric
junctions (Descarries et al., 1996), we injected lentiviral particles
encoding LGC-53 and the fluorescent protein Venus into the
dorsal striatum of P5 rat pups. Infected striatal neurons were
identified in brain slices 2 weeks after injection by fluorescence
and targeted for whole-cell recording (Fig. 5A,B). Presumably as
a result of restricted lentiviral expression (Fig. 5A), during nor-
mal handling of animals before tissue harvest, we noticed no
obvious behavioral abnormalities in LGC-53-injected animals.
However, systematic behavioral testing was not performed. We
investigated the properties of electrically evoked currents resis-
tant to GluR and GABAR blockers. In nontransduced neurons
filled with cesium gluconate pipette solution, evoked PSCs
mainly attributable to glutamate were observed at 70 mV.
Evoked PSCs attributable to GABA were evoked at 
20 mV.
PSCs were entirely eliminated by the combination of 1 M
NBQX, 25–50 M D-APV, and 5 M gabazine (Fig. 5C; 1.0 0%
of baseline; n 7). In contrast, transduced neurons often exhib-
ited an evoked outward current at
20 mV resistant to GABAAR
and GluR blockers (Fig. 5D). Residual current in 10 transduced
neurons was 39 14% of the baseline PSC amplitude (p	 0.05
compared with nontransduced controls). Compared with
GABAA IPSCs in the same neuron (Fig. 5D), putative LGC-53-
mediated currents had a similar latency but rosemore slowly (rise
time of evoked GABA IPSCs, 5.7  0.8 ms vs 23.5  3 ms for
residual currents after stimulation; Fig. 5D, inset; p 	 0.05).
Many residual PSC-like currents exhibited an inflection on the
rising phase (Fig. 5D, inset), reflecting temporally distinct com-
ponents of DA release explored further below.
To verify that residual PSCs in transduced neurons had char-
acteristics of LGC-53, we examined reversal potentials of the
PSCs using gluconate-based versus methanesulfonate-based pi-
pette solutions. Recordings obtained with a methanesulfonate
pipette solution exhibited a reversal characteristically more pos-
itive than recordings with a gluconate pipette solution (Fig.
5E,F). In contrast, GABAAR IPSCs in nontransduced neurons
exhibited a similar reversal potential regardless of whether glu-
conate or methanesulfonate was used as the major intracellular
anion (Fig. 5E,F). The dopaminergic nature of PSCs was further
verified by sensitivity of the PSC decays to the DA transporter
inhibitorGBR12909 (1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-
[3-phenylpropyl]piperazine; 1M; Fig. 5G,H).
We investigated whether LGC-53 imparted sensitivity to de-
tect unitary phasic DA release by examining spontaneous events
at 70 mV in chloride-filled cells. Under baseline conditions,
spontaneous transmission was evident in both transduced and
nontransduced neurons. In both cell types, this was mainly at-
tributable to GABA and glutamate transmission, because most
spontaneous events were blocked by a mixture of ionotropic
GluR and GABAR blockers (Fig. 5 I, J). However, in transduced
neurons (n 9 of 11 cells) but not nontransduced neurons (0 of
7 cells from the same cohort), infrequent events remained that
exhibited a time course characteristic of synaptic currents (Fig.
5I2; amplitude range,10 to50 pA). Average decay time con-
stant of these spontaneous events was 20 3 ms (n 9 neurons,
92 events in 40 min of total summated recording time). This
decay time constant was significantly faster than decay of evoked
responses to even the weakest stimuli presented (best-fit single-
exponential time constant for evoked phasic currents, 62 7ms;
Figure 4. Hijacking striatal synapses to probe LGC-53 as a postsynaptic sensor. A, Cultured
striatal neurons were transfected with LGC-53 plasmid DNA and marker GFP. At 10–12 d in
vitro, the culture was loaded with 70 mM DA plus 30 mM KCl for 5 min to load striatal synapses
with DA (Kim et al., 2000; Zhang and Zhou, 2002). Cells were then transferred to recording
medium containing 1M NBQX, 5M gabazine, and 25M D-APV. GFP-expressing cells were
clamped at70mV. The surrounding network was depolarized with 10mM total KCl to reveal
PSC-like events in transfected, DA-loaded cells but not other control conditions as indicated. B,
Summary of the spiperone-sensitive charge obtained from the experimental conditions indi-
cated (n 7–15 cells per condition). In summary, 12 of 15 transfected cells showed a revers-
ible, spiperone-sensitive response, whereas none of the 9, 8, and 7 cells in the three control
conditions, respectively, yielded a response. C, Striatal cells were grown in microcultures as
described previously (Moulder et al., 2007) and transduced with virus encoding LGC-53 and
Venus. Cultures of one to three neurons were stimulated in the presence of GluR and GABAR
blockers to obtain single-axon mediated PSCs, observed in a subset of transfected cells. Fast
inward currents preceding the PSC are stimulation currents associated with depolarization.
PSCs were sensitive to application of 10M DA plus 10M sulpiride to help suppress LGC-53
currents and block endogenous D2 presynaptic depression. The sulpiride and DA combination
hadno effect on autaptic GABA IPSCs (975%;n7), suggestingnopresynaptic effect of the
mixtureand suggesting that the suppressionof LGC-53PSCs results fromDA-mediated suppres-
sion. For summary data, see Results.
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amplitude, 119  28 pA; n  10). However, the decay time
constant was similar to that observed in evoked PSCs in culture
from false-transmitter loaded cells (Fig. 4C).We conclude that at
least a fraction of bona fide spontaneous phasic DA release is
captured by the LGC-53 sensor and that spontaneous release
exhibits faster transmitter clearance than electrically evoked DA
release.
We more closely examined the slow, asynchronous rise times
of LGC-53-mediated PSCs. We wondered whether the tempo-
rally distinct components could reflect direct and indirect com-
ponents of DA release, which have not heretofore been
temporally distinguished. With strong optogenetic stimulation
of the population of cholinergic interneurons, nicotinic-driven
DA release has been demonstrated (Cachope et al., 2012; Threlfell
et al., 2012; Nelson et al., 2014), occurring presumably through
activation of nAChRs onDA fibers (Jones et al., 2001).We exam-
ined whether the temporally distinct components might involve
direct (monosynaptic) and indirect (disynaptic) nicotinic recep-
tor (nAChR)-driven components of DA release by applying
nAChR antagonists. Both mecamylamine (10 M) and the 2-
selective antagonist DHE (1M) reduced the late component of
the PSC and left the rapidly rising early component (Fig. 6A,B).
The effect of nicotinic antagonists did not result from a direct
pharmacological effect of the drugs on LGC-53. In oocytes,
LGC-53 currents were not significantly affected by up to 5 min
preapplication of 10Mmecamylamine or 1MDHE (Fig. 6C).
The early PSC component in striatal neurons was not a break-
through glutamate EPSC because its reversal potential was indis-
tinguishable from that of the late component, either when part of
the compound PSC or when pharmacologically isolated (Fig.
6D,E). Furthermore, the early component was not a break-
through GABA current because it persisted in 100M picrotoxin
added to the omnipresent 10 M gabazine (Fig. 6F). The early
component was almost invariably smaller than the large compo-
nent and often was visible only with stronger stimulation inten-
sities. We conclude that local electrical stimulation elicits a
compound LGC-53-mediated PSC in striatal targets composed
of temporally distinct direct (monosynaptic) and a larger indirect
(disynaptic), nAChR-driven component of DA release.
The temporal distinction between nicotinic nAChR-evoked
and directly evoked release has not been observed previously and
highlights the utility of LGC-53. We looked more closely at the
temporal characteristics of the two components and relative
modulation by paired stimulation (Fig. 7). In the absence of
nAChR antagonist, the late PSC peak persisted even when stim-
ulus amplitude was reduced to simulate the overall suppressive
effect of nAChR antagonists (Fig. 7A). With weak stimulation,
PSCs also decayedmore rapidly, consistent with the idea that DA
overflow contributes to the decay of large PSCs (Fig. 7A,C). Con-
versely, PSCs in the presences of nAChR antagonists rose faster
and decayed faster than the compound PSC, even when com-
pound and nAChR-antagonized PSCs were matched for ampli-
Figure 5. Evoked and spontaneous LGC-53 currents from striatal slices. A, Lentiviral injec-
tions into the dorsal striatumproduced restricted expression in dorsolateral striatum. Scale bar,
500 m. B, High-magnification image of transduced and nontransduced neurons in a field
from the dorsolateral striatum. Whole-cell recording pipette (dashed outline) and field stimu-
lation pipette (solid outline) are evident in the right. Scale bar, 25 m. C, Recordings at the
indicated membrane potentials from a nontransduced striatal neuron, as identified by Venus
fluorescence. The red trace shows the response at
20 mV in the presence of 1M NBQX, 50
M D-APV, and 5M gabazine. Stimulus artifacts in this and the subsequent figures have been
blanked for clarity. D, In a transduced neuron, antagonist application revealed a residual cur-
rent. Inset, Scaled traces showing that the residual current has a slower rise to peak than the
4
peak-scaled mixed glutamate/GABA IPSC. E, F, Current–voltage characteristics of the
antagonist-insensitive, residual PSCsmirror those in transfected cultures (Fig. 1), including the
unique permeability to methanesulfonate (MeS). Curves in D represent PSCs normalized to
responses at
30 mV [gluconate (Gluc) and MeS responses] or90 mV (chloride responses).
G,H, Effects of theDA transport inhibitor GBR12909 (1M) on residual evokedPSCs. *p	0.05.
I, J, Spontaneous LGC-53-mediated transmission. I1, Total spontaneousPSCs froma transduced
neuron before wash in of NBQX, D-APV, and gabazine. I2, In the presence of antagonists, infre-
quent events remained (boxed events shown at higher resolution in I2). J, In a nontransduced
neuron, all events were eliminated by antagonists. For summary data, see Results.
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tude (Fig. 7B,C). This is despite the stronger stimulation
required in the presence of nAChR antagonist to generate
matched PSC amplitudes. Together, these results suggest a stron-
ger volumetric component to nAChR-driven DA release than to
direct release.
When stimulated with twin pulses at a 500 ms interval, com-
pound LGC-53 responses exhibited profound depression (Fig.
7A,B,D). Although we cannot entirely exclude receptor desensi-
tization as a contributor (see Discussion), the profound depres-
sion of the compound PSC did not primarily result from DA
overflow and receptor desensitization, because decreasing stim-
ulus intensity to reduce total DA output only mildly relieved the
profound paired-pulse depression (Fig. 7A). In nine cells with
PSC amplitude averaging 1556 472 pA,
we reduced stimulus amplitude to depress
the PSC by 74 3%, which only margin-
ally increased the paired-pulse ratio from
0.02  0.02 to 0.10  0.03 (Fig. 7A; p 
0.05, paired t test). In contrast to this small
effect, paired-pulse depression was signif-
icantly relieved when nicotinic receptors
were blocked and the early PSC compo-
nent was isolated (Fig. 7B,D). This differ-
ence persisted even when PSC amplitude
was matched across antagonist-treated
and untreated cells (Fig. 7B).
Presynaptic D2 receptors are best
known as autoreceptors on DA terminals.
However, D2 receptors are also localized
to axons and axon terminals of cholin-
ergic fibers in the striatum (Alcantara et
al., 2003). The relative effect of D2 recep-
tor stimulation on nicotinic-driven DA
release versus direct DA release is un-
known. We probed the relative contribu-
tion by examining the effect of the D2
receptor agonist quinpirole (2 M) on the
two components of evokedDA release. To
our surprise, D2 stimulation profoundly
depressed the late PSCwith amilder effect
on the early PSC (Fig. 8A,C). The quin-
pirole effect was reversed by coaddition of
the D2 receptor antagonist sulpiride (10
M; Fig. 8B,C). As expected from the ef-
fect of the D2 agonist on both the direct
and indirect components of DA release,
the paired-pulse ratio was strongly
elevated by quinpirole (Fig. 8A,D). We
conclude that D2 activation has a dispro-
portionate effect on the indirect, nAChR-
driven component of release, in contrast
to canonical views of a primarily autore-
ceptor function for D2 receptors.
Discussion
Here we introduce a simple method to
transform a slow transmitter into a fast
transmitter, thereby facilitating study of
rapid modulation of DA release, a trans-
mitter important to reward, volitional
movement, addiction, attention, and mo-
tivation. Unlike nACh, GABA, glycine, or
glutamate synapses, nature does not en-
dow mammalian DA target cells with re-
ceptors that can be readily exploited to study fundamental
features of spike-driven and spontaneous transmitter release. By
equipping DA target cells with a fast neurotransmitter receptor,
we revealed direct evidence for combined synaptic and volumet-
ric transmission. For the first time, we temporally dissociate di-
synaptic andmonosynaptic components of DA transmission and
demonstrate their differential modulation.
Our method has a number of advantages that make it readily
applicable. Unlike GABAARs and GluRs, LGC-53 is homomeric
and thus requires transduction/transfection of only a single sub-
unit. The low affinity and steady-state desensitization properties
render the receptor relatively insensitive to tonic DA levels but
Figure 6. Stimulus-induced activation of nAChRs is responsible for the late phase of DA release. A, A PSC from a transduced
neuron evoked before (black) and after application of an nAChR antagonism (blue; 10M mecamylamine). Inset shows a higher
time resolution to highlight the selective suppression of the late component of the PSC. Arrows indicate the biphasic components
as indicated.B, Summaryof the change inPSCamplitudeswithnAChRantagonism(n4,pooled10Mmecamylamineand1M
DHE; *p	 0.05). C, LGC-53 is not directly blocked by nAChR antagonists. Response of an oocyte expressing LCG-53 to 10M DA
(black line) after preapplication for 5 min of 1M DHE (blue line). Inset shows summary of normalized peak currents compared
with 10M DA alone (dashed line) from the same oocyte (n 3 for each antagonist). D, Current–voltage characteristics from a
transduced neuron with cesium gluconate internal solution before (black) and after (blue) 1M DHE. E, Graph shows summary
current–voltage relationship, normalized to peak responses at
30mV (n 3). F, The early component PSC (arrow) is retained
during application of 1M DHE in the presence of an additional GABAAR antagonist, 100M picrotoxin (PTX; 3 of 3 recordings).
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sensitive to transient levels of neurotransmitter that exceed 1
M.Desensitization properties are intermediate between AMPA-
type GluRs on one hand (desensitization time constant of 10
ms) and NMDARs and GABAARs on the other hand (several
hundred milliseconds desensitization time constant) and there-
fore do not hinder sensitivity to synaptic-like pulses of transmit-
ter. LGC-53 currents can be pharmacologically distinguished
from glutamate and GABA PSCs. The unique permeability char-
acteristics of LGC-53 suggest that, under carefully chosen exper-
imental conditions, LGC-53 responses can also be distinguished
from endogenous glutamate and GABA PSCs on the basis of
differential reversal potentials (Figs. 1C,D, 5E,F). Although in-
troduction of a foreign gene has risks of inducing unanticipated
Figure 7. Different temporal characteristics of early and late components of the compound
PSC. A, Effect of reduced stimulus amplitude (red trace) on PSC time course and paired-pulse
depression. The insets showthe twoPSCsafter scaling the first PSCpeak.B, Responses to500ms
paired stimuli in a neuron recorded in the absence (black) and another in the presence (blue) of
1 M DHE, matched in amplitude for the size of the PSC to highlight temporal differences.
Insets, Difference in time-to-peak between the antagonist-isolated early component and the
late component (absence of antagonist) PSC1 and development of PSC2 after nAChR antago-
nism (blue). Note the profound depression of PSC2 before nAChR block. C, Summary plot of the
difference in the time-to-peak and half-decay for both the antagonist-isolated early PSC1
(1037 22 pA) and late PSC1 (1000 22 pA). D, Summary plot of paired-pulse ratio
after nAChR antagonism (blue) (n 8 without antagonist, n 11 with antagonist; *p	
0.05).
Figure 8. Preferential modulation of disynaptic DA release by exogenous D2 receptor stim-
ulation.A, Paired-pulse response before (black) and after application of a D2 agonist (red; 2M
quinpirole). Insets show the disappearance of the late PSC1 after quinpirole (red) and a more
modest amplitude decrement in the early PSC1 response. Inset shows the development of PSC2
after elevated D2 receptor stimulation (red). PSC2 is displayed after subtracting current 5 ms
before stimulation.B, Additionof theD2 antagonist sulpiride (10M, gray) blocked the effect of
quinpirole. In the inset, the PSC is displayed after subtracting current 5msbefore stimulation.C,
Summary of the change in PSC amplitudes with D2 receptor stimulation [n 4 (red), n 3
(gray); *p	 0.05]. D, Increase in the paired-pulse ratio after elevated D2 receptor stimulation
can be occluded with a D2 antagonist (*p	 0.05). quin, Quinpirole; sulp, sulpiride.
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functional changes and adaptations, it can be argued that our
strategy is less invasive than amperometry, microdialysis, or even
optical probes, which can introduce tissue disruption and photo-
dynamic alterations.
However, the LGC-53 expression strategy suffers from some
disadvantages. Selectivity for DA is high, but care is needed be-
cause of the low sensitivity to NE and epinephrine. Fortunately,
NE release in the striatum seems unlikely to be a serious con-
found (Doucet et al., 1986). Furthermore, overlap in GABAAR
and LGC-53 antagonist pharmacology and off-target effects of
DA ligands at concentrations needed to modulate LGC-53 are
limitations. Surface LGC-53 expression levels can vary. Although
some of this variability could result from differences among tar-
get cells in the degree of DA innervation, surface expression vari-
ability likely also participates.
Are the LGC-53 responses from striatal neurons synaptic?
Spontaneous events appear to be closest to true synaptic events,
representing single-fiber and possibly even quantal transmission.
It seems likely that these events arise froma subset of the30%of
true synaptic appositions in striatum (Descarries et al., 1996).
Based on the decay time course, most evoked events involve a
component of volumetric spillover, with disynaptic nAChR re-
sponses exhibiting the strongest volumetric component. This
strong volumetric component likely results from the large spatial
coverage of the axon collaterals of the cholinergic interneurons
(Lehmann and Langer, 1983; Contant et al., 1996). A single local
electrical stimulus appears to activate widespread indirect release
ofDA, probably extendingwell beyondDA terminals near the site
of stimulation. The combined overflow from these terminals is
sensed by the target, recorded neuron. In contrast, the same stim-
ulus directly evokes release from a smaller subset of DA terminals
(Fig. 6). Even these smaller direct responses likely contain a vol-
umetric component, because a large majority of striatal DA ter-
minals aremorphologically nonsynaptic (Descarries et al., 1996).
In comparison, only 4% of terminals of the conventional fast
transmitter glutamate in the hippocampal CA1 region exhibit a
nonsynaptic morphology (Harris and Weinberg, 2012). Thus,
although LGC-53 is capable of detecting fast, quasi-synaptic re-
sponses (Fig. 4) with estimated “true” synaptic rise times of 	5
ms and decay times of20 ms given by false-transmitter exper-
iments, the microanatomy and physiology of DA connections
ensure mixed volumetric and quasi-synaptic responses.
Both direct and nAChR-indirect DA release exhibited strong
paired-pulse depression, implying a surprisingly high DA vesic-
ular release probability. This is in contrast to views of DA release
properties studied recently with optical techniques in dissociated
culture (Daniel et al., 2009; but see Cragg, 2003; Adrover et al.,
2014). High release probability is often associated with fast syn-
apses that require highly reliable postsynaptic activation (Zucker
and Regehr, 2002). The profound, nearly complete depression of
compound DA responses (Fig. 7) is consistent with the idea that
nAChR activation promotes a very high release probability in
terminals, thus usurping and occluding direct release (Threlfell et
al., 2012). Because of our use of a ligand-gated ion channel that
exhibits desensitization, we cannot exclude a role for desensitiza-
tion in the paired-pulse depression observed (Figs. 7, 8). How-
ever, a very recent study using amperometry, a technique not
subject to desensitization, also found evidence for strong paired-
pulse depression ofDA responses in rodent striatum (Wang et al.,
2014). This result validates our conclusion that high presynaptic
release probability and vesicle depletion are the main contribu-
tors to paired-pulse depression detected by LGC-53.
Our studies also reveal surprising differential modulation of
monosynaptic and disynaptic components byD2 receptor activa-
tion. DA is known to regulate cholinergic interneuron firing in
complex ways. An important effect of D2 receptor activation on
cholinergic interneurons is to decrease the high tonic firing rate
(Ding et al., 2010). D2 receptors are also present on cholinergic
presynaptic elements (Pisani et al., 2000; Alcantara et al., 2003).
However, the functionality of these receptors is unclear. Previous
results demonstrated that quinpirole reduces nAChR-driven DA
release, but the location of the D2 receptors remained unclear
(Threlfell et al., 2012). Our results suggest that D2 activation on
the ACh fibers themselves dramatically decreases cholinergic
output, resulting in nearly complete elimination of the indirect
DA response (Fig. 8). The weaker suppression of direct DA re-
lease suggests that the quinpirole effect cannot be accounted for
solely by D2 autoreceptors on the DA terminals. Thus, direct
presynaptic suppression can be added to the mechanisms of neg-
ative feedback regulation between the DA and cholinergic sys-
tems within the striatum.
Our studies reveal temporal facets of DA release in the dorsal
striatum. We temporally distinguish direct DA release from
stronger, nAChR-mediated release with longer-lived actions. We
demonstrate the differential modulation of monosynaptic and
disynaptic components by paired-pulse stimulation and an un-
expectedly strong effect of D2 receptor activation on the nAChR-
driven component of DA release.We conclude that heterologous
LGC-53 expression offers opportunities for studying DA in a
spatiotemporal domain that has been limited previously.
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